24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

Polymorphisms C677T and A1298C in MTHFR gene have been associated<br />

with a varying risk <strong>of</strong> cervical dysplasia . We evaluated the<br />

association <strong>of</strong> C677T and A1298C polymorphisms at the MTHFR<br />

locus with cervical intraepithelial neoplasia (CIN) or cervical cancer<br />

(CC) in Yucatan, Mexico, where CC is the first most common cancer.<br />

A case-control study was performed . Cases were 84 DNA samples <strong>of</strong><br />

women with CIN or CC (47 CIN I, 14 CIN II, 7 CIN III, 9 invasive cervix<br />

cancer and 7 cervical cancer) and controls were 127 DNA samples <strong>of</strong><br />

women who were negative to PAP . Polymorphisms were determined<br />

by PCR-RFLPs . Allele and genotype frequencies were compared between<br />

cases and controls in EpiInfo s<strong>of</strong>tware (OR, IC 95%) . Genotype<br />

frequencies in cases and controls were according to Hardy-Weinberg<br />

expectations (p>0 .33) for both polymorphisms . For C677T-MTHFR<br />

polymorphism, allele and genotype frequencies were not significantly<br />

different between cases and controls (p>0 .05), whereas for A1298C<br />

polymorphism, frequency <strong>of</strong> allele C was significantly different between<br />

cases and controls (P=0 .0325), suggesting an association <strong>of</strong><br />

1298C allele with a reduced risk to CIN or CC (OR 0 .51, IC 0 .25-0 .98) .<br />

Stratification according to phenotype showed that heterozygous genotype<br />

AC and allele C were associated only with CIN I, p= 0 .023 and p=<br />

0 .0180, respectively . Our results suggest that polymorphism A1298C<br />

in MTHFR gene is associated to CIN I as a protective factor to develop<br />

more severe dysplasias in Yucatan population .<br />

P06.187<br />

mtHFR gene polymorphisms and neural tube defects - the<br />

incidence in slovak population.<br />

J. Behunova 1 , L. Klimcakova 2 , D. Potocekova 3 , L. Podracka 1 ;<br />

1 I. Department <strong>of</strong> Pediatrics, Safarik University Children Hospital, Kosice, Slovakia,<br />

2 Department <strong>of</strong> Medical Biology, Safarik University School <strong>of</strong> Medicine,<br />

Kosice, Slovakia, 3 Department <strong>of</strong> Informatics, Safarik University School <strong>of</strong><br />

Medicine, Kosice, Slovakia.<br />

Neural tube defects (NTD) belong to the most debilitating birth anomalies<br />

. The geographical & historical differences in NTD incidence vary<br />

tremendously - from 8/1000 till 0,21/1000 . Discovery <strong>of</strong> folic acid´s preventive<br />

effect influenced the research <strong>of</strong> NTD genetic background focusing<br />

to the genes whose products take part in the folate metabolism .<br />

One <strong>of</strong> the most important enzymes involved is MTHFR - methylenetetrahydr<strong>of</strong>olate<br />

reductase whose common termolabile variant C677T<br />

in homozygote state reduces MTHFR activity to 30-40% <strong>of</strong> norm . Lowered<br />

activity might play a crucial role in early embryonic development .<br />

That is why this polymorphism has been investigated in various NTD<br />

populations and in some <strong>of</strong> them the mutant variant has been proven<br />

to be a risk factor for failure <strong>of</strong> neural tube closure .<br />

In Slovakia with average natality about 50 000 liveborn per year, there<br />

are anually 10-20 children born with NTD (0,28/1000) - mostly with<br />

meningomyelocele . When including stillborn and selective abortions,<br />

the number <strong>of</strong> NTD pregnancies is even higher (0,35-0,52/1000) . To<br />

evaluate genetic risk <strong>of</strong> folate metabolism variations in our population,<br />

we investigated MTHFR gene polymorphisms C677T and A1298C in<br />

91 Slovak children with NTD . The obtained results <strong>of</strong> genetic analyses<br />

are being compared with those from 300 newborns from Slovak population<br />

. Currently we got the results <strong>of</strong> C677T polymorphism analysis,<br />

which, however, did not show any significant difference in the prevalence<br />

<strong>of</strong> TT genotype or T allele between the patients and controls (OR<br />

= 1,22 [95% CI 0,5-2,9]; OR = 1,16 [CI 0,8-1,7] respectively) .<br />

P06.188<br />

Use <strong>of</strong> a Genetic isolate to identify Rare ms Variants<br />

S. P. Kallio 1 , E. Jakkula 1,2 , S. Purcell 2,3 , M. Suvela 1 , K. Koivisto 4 , P. J. Tienari 5 ,<br />

M. L. Sumelahti 6 , I. Elovaara 7 , T. Pirttilä 8 , M. Reunanen 9 , D. Bronnikov 1 , M.<br />

Viander 10 , J. Hillert 11 , F. Lundmark 11 , H. F. Harbo 12 , Å. R. Lorentzen 13,14 , P. L. De<br />

Jager 2,15 , M. J. Daly 2,3 , D. A. Hafler 2,15 , A. Palotie 1,2 , L. Peltonen 1,16 , J. Saarela 1 ;<br />

1 National Public Health Institution, University <strong>of</strong> Helsinki and FIMM, Helsinki,<br />

Finland, 2 The Broad Institute <strong>of</strong> Harvard and MIT, Cambridge, MA, United<br />

States, 3 Center for <strong>Human</strong> Genetic Research, Massachusetts General Hospital<br />

and Harvard Medical School, Boston, MA, United States, 4 Central Hospital <strong>of</strong><br />

Seinäjoki, Seinäjoki, Finland, 5 Department <strong>of</strong> Neurology, University <strong>of</strong> Helsinki,<br />

Helsinki, Finland, 6 School <strong>of</strong> Public Health, University <strong>of</strong> Tampere, Tampere,<br />

Finland, 7 Department <strong>of</strong> Neurology, Tampere University Hospital, Tampere,<br />

Finland, 8 Department <strong>of</strong> Neurology and Neuroscience, Kuopio University Hospital,<br />

Kuopio, Finland, 9 Department <strong>of</strong> Neurology, Oulu University Hospital, Oulu,<br />

Finland, 10 Department <strong>of</strong> Medical Microbiology and Immunology, University <strong>of</strong><br />

Turku, Turku, Finland, 11 Department <strong>of</strong> Clinical Neuroscience, Karolinska Institutet<br />

at Karolinska University Hospital-Huddinge, Stockholm, Sweden, 12 Department<br />

<strong>of</strong> Neurology, Ullevål University Hospital, Oslo, Norway, 13 Institute <strong>of</strong><br />

Immunology, Rikshospitalet University Hospital, Oslo, Norway, 14 Department <strong>of</strong><br />

Neurology, Faculty Division Ullevål University Hospital, University <strong>of</strong> Oslo, Oslo,<br />

Norway, 15 Department <strong>of</strong> Neurology, Center for Neurologic Diseases, Brigham<br />

and Women’s Hospital and Harvard Medical School, Boston, MA, United<br />

States, 16 Wellcome Trust Sanger Institute, Cambridge, United Kingdom.<br />

MS is a chronic inflammatory disease <strong>of</strong> the CNS with complex inheritance<br />

. The etiology <strong>of</strong> MS is poorly understood . Large case-control association<br />

studies primarily aim to identify common variants contributing<br />

to pathogenesis <strong>of</strong> common traits . To tackle rare alleles contributing to<br />

the molecular background <strong>of</strong> MS, alternative strategies are needed .<br />

One approach is to use special populations with a founder effect and<br />

isolation, where one could hypothesize allelic enrichment . Such a<br />

unique high-risk region for MS is the Southern Ostrobothnia in Finland,<br />

where both the prevalence and familial occurrence are exceptionally<br />

high . We have performed a high-resolution genome-wide SNP study<br />

using the Illumina <strong>Human</strong>Hap300 panel to monitor, which alleles are<br />

shared by 72 familial MS cases from this high-risk isolate . Genealogical<br />

studies showed that majority <strong>of</strong> these patients are distantly related .<br />

Genotype data <strong>of</strong> 68 IBS-matched Finns was used as controls . We<br />

first focused on the 45Mb region on 5p, for which we have shown linkage<br />

in Finnish MS-families . The haplotype analysis over this region<br />

revealed association with one haplotype, and the finding was validated<br />

in a larger study set from the high-risk region (OR 2 .73, p=3 .2x10 -6 ) .<br />

The identified risk-haplotype flanks two genes, C7 (complement component)<br />

and FLJ40243 (predicted protein) . Suggestive association<br />

with C7-FLJ40243 alleles and MS was also seen in more heterogeneous<br />

populations . Interestingly, plasma C7 protein levels and total<br />

complement activity were observed to correlate with the risk-haplotype<br />

identified. Sequencing <strong>of</strong> the 31kb C7 region did not reveal an obvious<br />

causative variant . Sequencing <strong>of</strong> FLJ40243 is in progress .<br />

P06.189<br />

Genetic polymorphysms <strong>of</strong> iL12B and VDR in association with<br />

multiple sclerosis in russians<br />

S. Babenko1 , J. Orlova2 , V. Alifirova2 , V. Pusyrev1,2 ;<br />

1 2 Institute <strong>of</strong> Medical <strong>Genetics</strong>, Tomsk, Russian Federation, Siberian State<br />

Medical University, Tomsk, Russian Federation.<br />

We investigated genotypes and haplotypes frequencies for VDR and<br />

IL12B polymorphisms in case-control studies <strong>of</strong> MS in 92 Russian<br />

inhabitants <strong>of</strong> Tomsk region. Our results show significant differences<br />

<strong>of</strong> alleles and genotypes frequencies in the distribution <strong>of</strong> the polymorphism<br />

1188A>C IL12B between MS patients and controls (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!